Solstice Neurosciences, LLC

This study looked at the safety and immune response of MYOBLOC (botulinum toxin type B) injections in 502 adults with cervical dystonia, a condition causing painful neck muscle spasms. Participants received injections and were monitored for about 12 weeks. The goal was to see if …

This study tested whether injections of Myobloc (botulinum toxin type B) into the salivary glands can safely reduce drooling in people with Parkinson's disease. Fifty-four participants received either Myobloc or a placebo. The main goal was to see if drooling severity and frequen…

This study tested the safety and effectiveness of repeated MYOBLOC injections over one year in 187 adults with troublesome drooling caused by conditions like Parkinson's disease, stroke, or ALS. Participants received up to four treatment sessions, and researchers tracked side eff…

This Phase 3 study tested whether injections of MYOBLOC (a botulinum toxin type B) into the salivary glands can safely reduce troublesome drooling in adults. 187 participants received either MYOBLOC or a placebo. The main goals were to measure changes in saliva flow and overall i…